1. Home
  2. MDGL vs IPG Comparison

MDGL vs IPG Comparison

Compare MDGL & IPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • IPG
  • Stock Information
  • Founded
  • MDGL 2011
  • IPG 1902
  • Country
  • MDGL United States
  • IPG United States
  • Employees
  • MDGL N/A
  • IPG N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • IPG Advertising
  • Sector
  • MDGL Health Care
  • IPG Consumer Discretionary
  • Exchange
  • MDGL Nasdaq
  • IPG Nasdaq
  • Market Cap
  • MDGL 9.6B
  • IPG 9.7B
  • IPO Year
  • MDGL N/A
  • IPG N/A
  • Fundamental
  • Price
  • MDGL $423.00
  • IPG $25.56
  • Analyst Decision
  • MDGL Strong Buy
  • IPG Buy
  • Analyst Count
  • MDGL 12
  • IPG 6
  • Target Price
  • MDGL $521.09
  • IPG $31.10
  • AVG Volume (30 Days)
  • MDGL 277.8K
  • IPG 6.8M
  • Earning Date
  • MDGL 11-04-2025
  • IPG 10-21-2025
  • Dividend Yield
  • MDGL N/A
  • IPG 5.12%
  • EPS Growth
  • MDGL N/A
  • IPG N/A
  • EPS
  • MDGL N/A
  • IPG 1.18
  • Revenue
  • MDGL $515,547,000.00
  • IPG $8,846,600,000.00
  • Revenue This Year
  • MDGL $394.38
  • IPG N/A
  • Revenue Next Year
  • MDGL $64.73
  • IPG $2.71
  • P/E Ratio
  • MDGL N/A
  • IPG $21.76
  • Revenue Growth
  • MDGL 3421.98
  • IPG N/A
  • 52 Week Low
  • MDGL $213.71
  • IPG $22.51
  • 52 Week High
  • MDGL $463.63
  • IPG $33.05
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 46.03
  • IPG 41.45
  • Support Level
  • MDGL $413.82
  • IPG $26.89
  • Resistance Level
  • MDGL $436.79
  • IPG $28.24
  • Average True Range (ATR)
  • MDGL 18.12
  • IPG 0.69
  • MACD
  • MDGL -2.63
  • IPG -0.10
  • Stochastic Oscillator
  • MDGL 48.76
  • IPG 4.25

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About IPG Interpublic Group of Companies Inc. (The)

Interpublic Group is among the world's largest advertising holding companies based on annual revenue. It provides traditional advertising services along with digital and other services, such as public relations, through various acquisitions. IPG has made these services available in over 100 countries. The company generates about 65% of revenue in the US and 17% in the UK and Europe.

Share on Social Networks: